SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,660,229 | +47.3% | 35,309 | +31.4% | 0.08% | +81.8% |
| Q1 2023 | $1,127,423 | -41.0% | 26,869 | -46.3% | 0.04% | -37.1% |
| Q4 2022 | $1,909,555 | +133.7% | 50,067 | +160.8% | 0.07% | +118.8% |
| Q4 2021 | $817,000 | +46.7% | 19,195 | +52.8% | 0.03% | +60.0% |
| Q3 2021 | $557,000 | -88.2% | 12,561 | -84.9% | 0.02% | -81.5% |
| Q2 2021 | $4,711,000 | +221.1% | 82,933 | +323.1% | 0.11% | +134.8% |
| Q1 2021 | $1,467,000 | +149.1% | 19,603 | +187.9% | 0.05% | +130.0% |
| Q4 2020 | $589,000 | -86.2% | 6,810 | -90.2% | 0.02% | -96.5% |
| Q3 2020 | $4,265,000 | – | 69,784 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |